EvoNK Preemptive immune management for cancer prevention

Why is preemptive family history management necessary?

Limitations of existing treatments Differences between LACELLIC

Why EvoNK Proactive Management is Different

EvoNK immune cell therapy

The key to family history preemptive immunity suggested by LACELLIC

LACELLIC Cancer Prevention Medical Tour

LACELLIC Medical Tour Package If you have a family member diagnosed with cancer, you may face the question, “How should I manage the time between checkups?” while receiving regular checkups.

There are people who are said to be at a higher risk of developing cancer than the general public due to genetic factors or family history.

However, since an individual's condition cannot be determined solely by the fact that there is a family history, confirmation through tests and medical treatment is given priority.

Existing preventive care is often carried out by periodically monitoring the condition through regular checkups. There has been ongoing discussion about the vague anxiety that remains between checkups.

Recently, research on approaches to prepare in advance using immune cells is also continuing. Our body’s NK cells and LACELLIC’s EvoNK preemptive immune management

NK cells (natural killer cells) are cells known to play a role in recognizing and responding to abnormal cells in our body's immune system, and are an area of ​​ongoing research related to cancer.

LACELLIC's EvoNK is an immune cell therapy platform that aims to go beyond simply collecting and culturing cells and engineer them so that they can function for a long time in the body.

LACELLIC's points of view in family history preemptive immune support management are as follows.

• Blocks cancer risk factors in advance • Real-time tracking of micro-mutated cells • Safe without damaging normal cells • Establishes overall immune balance in the body

The program is reviewed in a prevention-only format for those who want to manage potential risks along with a healthy routine. It is designed to increase basic immunity, and through immune cell target recognition technology, abnormal cells that may occur due to family history are examined.

Here, double NK activation technology is applied

It is designed to look at potential cancer stem cells (CSCs, cells known to be highly resistant to treatment).

However, the extent of family history, current health status, and check-up history received are all different for each individual.

Rather than uniformly applying a specific method, priority is given to comprehensively examining the current condition, consulting with medical staff, and reviewing individual application and plans.

It is important to continue your existing health care, including regular checkups, under the guidance of your medical staff. The immune cell program is not a replacement for this. Medical tour information for overseas patients

If you are visiting from overseas, you must consider not only treatment and programs but also your itinerary before and after your visit to Korea.

LACELLIC provides consultation on treatment schedules and medical tourism so that overseas visitors can more conveniently prepare their domestic treatment schedule. Information on movement and stay after arrival at the airport, remote tracking of immunity levels and follow-up care after returning home is also provided.

The specific scope of support may vary depending on the schedule and program and can be confirmed through prior consultation. The application method for cancer family history and preemptive immune support program may vary depending on the individual's condition.

EvoNK also prioritizes the process of confirming applicability based on sufficient testing and consultation with medical staff. Treatment effectiveness may vary depending on the individual.

LACELLIC Clinic, 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul

71-9 Samseong-dong, Gangnam-gu, Seoul

Inquiry +82 10-7667-6057

LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul